Company watch: Regulatory risks may weigh on Bain Capital-backed Emcure Pharma
10 July, 2017
Photo Credit: Thinkstock
India’s generics pharmaceutical industry has been hit over the past few years ever since the US Food and Drug Administration tightened its inspections of factories in the country.The regulator has ...
TO READ THE FULL STORY
The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced